Initially, 11 compounds consisting of both BET inhibitors and BET degraders were screened at a concentration of 1 μM, to determine their ability to induce cell death in DLBCL cell lines (Fig. 1a). This evidence concerns the gene DNER and diffuse large B-cell lymphoma.